Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pain Outcomes Following Hip Arthroscopy: Fascia Iliaca Blockade vs Liposomal Bupivacaine
NCT04114058Phase 4Completed
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Oct 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Cedars-Sinai Medical Center. Primary endpoint: Visual Analogue Scale. Started Oct 2019; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04114058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04114058.